Show simple item record

dc.date.accessioned2016-01-09T00:20:02Zen
dc.date.available2016-01-09T00:20:02Zen
dc.date.created2002-05en
dc.date.issued2002-05en
dc.identifier.bibliographicCitationRockville, MD: Center for Biologics Evaluation and Research, 2002 May; 10 p. [Online]. Available: http://www.fda.gov/cder/guidance/3764fnl.htm [2003 February 11]en
dc.identifier.urihttp://www.worldcat.org/search?q=ti%3AGuidance+for+industry%3A+special+protocol+assessment&qt=advanceden
dc.identifier.urihttp://hdl.handle.net/10822/1010609en
dc.languageenen
dc.publisherCenter for Biologics Evaluation and Research [CBER] (United States); Center for Drug Evaluation and Research [CDER] (United States)en
dc.sourceeweb:246125en
dc.subjectIndustryen
dc.subject.classificationSocial Control of Science and Technologyen
dc.subject.classificationDrugs and Drug Industryen
dc.titleGuidance for Industry: Special Protocol Assessmenten
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2017 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885